Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis.
- Resource Type
- Article
- Source
- CEN Case Reports; Feb2023, Vol. 12 Issue 1, p27-31, 5p
- Subject
- Language
- ISSN
- 21924449